Orthobiologics company OrthoSera launched the BoneAlbumin for musculoskeletal indications.
Here are four key notes on the technology:
1. BoneAlbumin is a serum albumin enhanced bone substitute made of fully human materials of donated bone and blood.
2. The patented albumin coating technology went through clinical trials to show positive affects.
3. The product is classified as a "human tissue product" which means there could be distribution throughout regional tissue banks.
4. OrthoSera is headquartered in Krems/Austria and has subsidiaries in the United States and Hungary. The company was formerly known as Lacerta.